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Mechanisms and kinetics for platelet and neutrophil localization In
Immune complex nephritis. We have previously reported that both
neutrophils (PMNs) and platelets mediate proteinuria in a model of
subendothelial immune complex (IC) nephritis (GN) in the rat. In order
to understand the interaction of PMNs and platelets in this model, we
quantitated the uptake of 'In-labelled platelets in glomeruli and
correlated this with the number of PMNs observed histologically at 10
and 30 minutes, 1, 4 and 24 hours following induction of GN. Platelet
accumulation was biphasic with a major peak at 10 minutes and a minor
peak at four hours. Early platelet accumulation was complement
dependent, and PMN-independent. PMN accumulation occurred after
the initial platelet influx, peaking at one and four hours, was comple-
ment dependent, but was not affected by platelet depletion. Comple-
ment depletion significantly reduced proteinuria. This is the first docu-
mentation that platelet accumulation in glomeruli in IC GN is
complement dependent. In addition, the enhancement of PMN-medi-
ated injury by the platelet in this model does not involve effects of
platelets on PMN localization, thus implying a functional interaction
between these cells within the glomerulus.
The platelet may be an important mediator in glomerulone-
phritis (GN) [reviewed in 1, 2]. Platelets contain many pro-
inflammatory substances, including vasoactive amines, growth
factors, cationic proteins, thromboxane and proteases. Several
studies have suggested that platelets, perhaps via the release of
these products, may mediate immune complex deposition [3],
mesa'---ial cell proliferation [4], and changes in capillary wall
permeability [5] in glomerular injury.
Although platelets may be capable of inducing tissue injury
alone, in many inflammatory disorders platelets are accompa-
nied by neutrophils (PMNs) [6—10]. The observed association of
platelets with PMNs has also been noted in both experimental-
ly-mediated [11—16] and human [17] GN. Given the frequent
coexistence of platelets and PMNs in GN, a potential interac-
tion of these inflammatory cells in mediating glomerular injury
may be important. This is supported by in vitro studies that
demonstrate that under certain conditions platelets can increase
PMN adherence, phagocytosis, and release of myeloperoxidase
and reactive oxygen species [18—23]. PMNs can activate plate-
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lets as well [24]. A potential interaction between platelets and
PMNs is further suggested by recent in vivo studies in rodents
in which platelets were required for the development of PMN-
mediated lung injury that follows systemic activation of com-
plement [9, 10].
We have studied a model of immune complex nephritis in the
rat characterized by predominantly subendothelial immune
complex deposits, glomerular deposition of C3, and marked
platelet and PMN infiltration [16, 25]. When rats were made
neutropenic with an anti-PMN serum the glomerular PMN
infiltrate was abolished and the proteinuria significantly reduced
[25]. However, rats made selectively thrombocytopenic with an
antiplatelet IgG also had minimal proteinuria, despite the pres-
ence within glomeruli of numerous PMNs [16]. These findings
suggest an important role for platelets in this PMN-mediated
model of glomerular injury.
To better understand the interaction of the PMN and platelet
in this disease model of immune complex nephritis, we have
undertaken studies utilizing "In-labelled platelets to quantitate
the amount, kinetics and mechanisms of platelet accumulation
in glomeruli and to correlate these findings with PMN localiza-
tion as assessed by histology. Our studies demonstrate that
platelet accumulation occurs within 10 minutes of subendo-
thelial immune complex formation and precedes PMN localiza-
tion. Both PMN and platelet localization are complement-
dependent and are largely independent of each other. These
findings provide further evidence for platelet-PMN involvement
in glomerular disease.
Methods
Description of immune complex GN
Immune complex ON was induced in rats by the selective
renal artery perfusion of the lectin concanavalin A (con A)
followed by anti-concanavalin A antibody, as described previ-
ously [16, 25]. The infusion of con A results in binding to
glucose and mannose residues on glomerular endothelial cells
and basement membrane (GBM) glycoprotein, and hence al-
lows it to function as a "planted" antigen [26]. The subsequent
perfusion of anti-con A antibody results in marked endothelial
cell injury, complement activation, PMN and platelet infiltra-
tion, fibrin deposition, and the formation of extensive subendo-
thelial and lesser subepithelial immune complex deposits [16,
25, 26].
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Renal artery perfusion
The technique for inducing GN with con A and antibody to
con A has been described in detail previously [16]. Briefly, male
Sprague-Dawley rats (Tyler Labs, Bellevue, Washington, USA)
weighing between 200 and 300 g were anesthetized with equith-
esin (pentobarbitol and chioral hydrate) i.p. (0.3 cc per 100 g
body wt) and a left nephrectomy performed. The aorta was then
isolated above and below the right renal and superior mesen-
teric arteries and blood flow was interrupted. The superior
mesenteric artery was cannulated in a retrograde manner with a
30 gauge needle and the right kidney perfused using a constant
infusion pump (Sage Instrument Div., Orion Research Inc.,
Cambridge, MA, USA) at a rate of 0.75 mI/mm on a heated
operating table. The kidney was initially perfused with 0.5 ml
phosphate buffered saline, pH 7.2 (PBS) followed by 1.0 ml of
PBS containing 125 g con A (ICN Biomedicals, Costa Mesa,
CA, USA). After a flush of the cannula with 0.2 ml PBS, an
additional infusion of polyclonal rabbit anti-con A IgG (19 mg in
0.5 ml PBS) followed by PBS (0.3 ml) was performed. The
preparation of the anti-con A IgG has been described previously
[25]. Blood flow was then restored to the kidney, the needle
removed, and bleeding from the puncture site was stopped by
the application of gelfoam (Upjohn Co., Kalamazoo, Michigan,
USA) and gentle pressure. Total ischemia of the kidney was
always less than eight minutes. The abdominal wound was then
closed and the animal was placed under a heat lamp for one to
two hours until he had recovered from anesthesia.
Preparation of "In-platelets
Platelets were labelled with 111lndiumoxine using a method
adapted from Issekutz et al [27]. Six ml of blood was drawn by
cardiac puncture from a normal rat into an equal volume of acid
citrate dextrose. The blood was centrifuged at 300 g for 10
minutes at room temperature and the upper 2/3 of the platelet-
rich plasma was removed. The platelets were isolated by repeat
centrifugation at 800 g for 20 minutes. The platelet pellet was
washed with Ca-Mg-free Hanks Balanced Salt Solution
(HBSS), pH 6.9 and the platelets were collected after centrifu-
gation at 800 g for an additional 20 minutes. The platelet pellet,
containing 1 to 1.5 x l0 platelets, was suspended in 2 ml
HBSS, and 10 pCi of "In-oxine (Amersham, Arlington
Heights, Illinois, USA) was added drop-wise and the platelets
incubated for 15 minutes at room temperature with occasional
shaking. Twenty ml of HBSS containing 1% bovine serum
albumin (Sigma, St. Louis, Missouri, USA) was then added,
and the platelet pellet was obtained after centrifugation at 800 g
for 20 minutes. The platelets were then resuspended in 4 ml
HBSS, and an aliquot removed for measurement of absolute
platelet count (by phase microscopy [16]) and for uptake of
"In-oxine.
For each experiment, 108 "In1abelled platelets were infused
intravenously into rats that had been lightly anesthetized with
ether. Each infusion also contained 0.5 pCi of rat IgG (Miles,
Naperville, Illinois, USA), that had been labelled with 125! by
the chloramine T method [28] to act as a blood marker.
Assuming that the total blood volume of a rat is 7% of body
weight, 73% of the infused platelets in PBS perfused rats were
circulating at 1 hour with 96% of the "In remaining platelet
associated.
Quantitation of platelet accumulation in glomeruli
One hour following the intravenous infusion of "tIn-labelled
platelets and '251-labelled rat IgG, the rat was anesthetized and
a heparinized blood sample was collected by cardiac puncture.
A kidney biopsy was then obtained for histologic studies, the
rat sacrificed, and the kidney removed.
The platelet count in the blood sample was determined, and
the number of cpm of '"In and 1251 were measured using a Prias
Autogamma counter (Packard Instrument Co., Donners Grove,
Illinois, USA) and was corrected for background and overlap of
the "In energy emission into the 1251 channel. The blood was
then centrifuged at 10,000 g x 5 minutes and the "free" plasma
"In and platelet-associated "In measured. The number of
platelets circulating per platelet-associated "In cpm was cal-
culated using the formula:
Platelet specific activity =
# of platelets/mi blood
# cpm of platelet-associated "In/mi blood
The glomeruli were isolated from the cortex of the removed
kidney by differential sieving [28]. The isolated glomeruli were
counted visually using a Fuchs-Rosenthal hemocytometer
(Hausser Scientific Co., Blue Bell, Pennsylvania, USA) [28]
and the glomerular uptake of "In and 125! measured. The
number of platelets per glomerulus was calculated based on the
specific activity of the platelets in the blood and after correcting
for nonspecific blood contamination as reflected by 125j reten-
tion in the glomerular pellet using the formulas:
Specific glomerular uptake "In =
# platelets/glom =
B "In"
"In — G
125I( B 125!)
platelet specific activity
x specific glomerular uptake 11In
Where G "In and G 1251 are cpm of "In and 125! in an aliquot
of glomeruli and B "In and B 125! are cpm of "In and 125! in
I ml of whole blood.
Experimental protocol
Immune complex GN was induced in rats by the renal artery
perfusion of con A and anti-con A antibody as detailed above
(N = 21). Control rats underwent renal artery perfusion with
PBS alone (N = 16). Other groups studied included rats with
immune complex GN that had been previously depleted of
complement (N = 19), leukocytes (N = 16), or platelets (N =
12). Representative values for WBC, PLT and C3 levels at the
time of disease induction for each of these groups are shown in
Table 1.
For each group of rats (except the platelet-depleted group) an
infusion of "In-labeled platelets and '251-labelled rat IgG was
administered one hour prior to sacrifice. Representative rats
were sacrificed at different times following renal artery perfu-
sion (that is, 10 mm, 30 mm, 1 hr, 4 and 24 hrs). At the time of
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Table 1. Leukocyte and platelet counts, and C3 levels at the time of
induction of GN in normal, complement depleted, WBC depleted and
platelet depleted rats
WBC
#1mm3
PLT
thousands/mm3
C3
% of baseline
Normal 14,132 1059 764 44 98 6
C depleted 25,500 3088 756 46 4 2
WBC depleted 80 10 556 52 111 4b
PLT depleted 20,800 2420 3.5 1.4 61 2
Abbreviations are: C, complement; PLT, platelet; WBC, leukocyte.
a Compared to pooled normal rat plasmab Obtained 10 minutes after renal artery perfusion in 4 rats
sacrifice the blood was sampled for white cell and platelet
counts and C3 levels, renal tissue was obtained for histologic
studies, and the number of platelets per glomerulus was quan-
titated. Rats that were studied at 24 hours were kept in
metabolic cages overnight and urine was collected for analysis
of protein excretion using the sulfosalicylic acid method [29].
Complement (C) depletion
Rats were depleted of complement with cobra venom factor
(CVF; Naja Naja kaounthia, Diamedix Corporation, Miami,
Florida, USA) [30]. Rats were injected with CVF 300 sJkg i.p.
in three divided doses beginning 24 hours prior to renal artery
perfusion and received an additional dose of 100 slkg i.p. on the
day of surgery and induction of GN. Serial serum C3 concen-
trations were measured by radial immunodiffusion [31] to
monitor the complement status of the animals. Serum C3
concentrations on the day of renal artery perfusion and at the
time of sacrifice averaged <5% of the baseline serum C3 level
obtained before the first injection of CVF (Table 1). CVF-
treated rats exhibited a leukocytosis but had normal platclet
counts (Table 1).
Leukocyte (WBC) depletion
Rats were depleted of leukocytes (WBC) by irradiation with
shielding of the right kidney in a method modified from Tucker
et al [321. Following anesthesia with equithesin, rats were
placed on a rotating platform and the right kidney was shielded
with a 3 cm thick lead block. Rats received 800 total rads at a
rate of 20 rads/min using a unidirectional '37Cs source. Dosim-
etry studies have confirmed that the shielded kidney receives
less than 10% of the total dose (that is, 60 to 70 rads). Three
days following irradiation rats also were given 1.0 ml anti-PMN
serum i.v., that has been described previously [25]. On day 4
the renal artery perfusion of con A and anti-con A was
performed. At the time of surgery all 16 rats had severe
leukopenia (mean 80/mm3) and an absence of PMNs (0/mm3;
Table 1). The platelet count was slightly depressed but comple-
ment levels were normal (Table 1). In contrast, rats studied 24
hours after induction of GN (that is, dayS post-irradiation) were
leukopenic (mean WBC <75/mm3) and thrombocytopenic (pit
ct 50,000 8,000/mm3), at the time of sacrifice.
Platelet depletion
Rats were depleted of platelets with polyclonal goat antiplate-
let IgG [16]. A dose of 40 to 50 mg/lOO g body weight i.p. results
in a selective thrombocytopenia (mean pit count <10,000/mm3)
within eight hours and is sustained for over 40 hours. The
platelet and WBC counts and C3 levels in platelet depleted rats
at the time of induction of GN are shown in Table 1. As has
been previously shown [16], platelet depleted rats had a leuko-
cytosis and a modest depression in C3.
Renal histology
Tissue for light microscopy was fixed in Sorensen's buffered
formalin (10% formalin in 0.1 M Na phosphate buffer, pH 7.2)
for at least four hours, and was then dehydrated in graded
ethanols and embedded in glycomethylmethacrylate (Poly-
science, Warrington, Pennsylvania, USA). Sections (2 to 3 pm)
were stained with periodic acid Schiff (PAS) reagent.
Quantitation of the number of PMNs present per glomerular
cross section was performed on the PAS stained sections in a
blinded fashion. Ten representative glomeruli from each biopsy
were counted. Glomerular cross sections containing only a
minor portion of the glomerular tuft (that is, less than 20
discrete capillary segments) were not included in the analysis.
Tissue for immunofluorescence (IF) was embedded in O.C.T.
(Lab-Tech products, Miles, Naperville, Illinois, USA), snap-
frozen in isopentane, and sectioned with a Tissue-Tek II
Microtome/Cryostat (Miles) [16]. Con A was detected by indi-
rect immunofluorescence using a biotinylated goat anti-con A
antibody (Vector Labs, Burlingame, California, USA) followed
by fluorescein isothiocyanate (FITC)-conjugated strepavidin
(Amersham). Rabbit anti-con A IgG was detected using FITC-
conjugated goat anti-rabbit IgG, rat C3 with FITC-conjugated
goat anti-rat C3 and rat fibrin with FITC-conjugated goat
anti-rat fibrinogen (Organon Teknika Corp., BCA Cappel, West
Chester, Pennsylvania, USA). Rat CSb-9 was detected by
indirect IF using a biotinylated mouse anti-rat CSb-9 antibody
that we have previously characterized [33] followed by FITC-
strep avidin (Amersham). Sections were examined with a Leitz
Ortholux II microscope with a Ploempak 2.2 vertical fluores-
cence illuminator (E. Leitz Inc., Rockleigh, New Jersey, USA)
and the intensity was graded semi-quantitatively from 0 to 4+
as described previously [16].
Tissue for electron microscopy (EM) was fixed in half-
strength Karnovsky's Solution (1% paraformaldehyde and
1.25% glutaraldehyde in 0.1 M Na cacodylate buffer, pH 7.0),
post-fixed in osmium tetroxide, dehydrated in graded ethanols,
and embedded in epoxy resin. Thin sections were stained with
uranyl acetate and lead citrate and examined with a Philips 410
(Philips Export BV, Eindhoven, The Netherlands) electron
microscope.
Analysis of data
All values are mean SE. Groups were compared using the
one way analysis of variance (ANOVA) in which multiple
comparisons were made with the Bonferroni method [34]. The
analysis of the "In-labeled platelet localization was performed
on logarithmic transformed data to stabilize the variances.
Results
Glomerular localization ofimmune deposits, platelets and
PMNs in immune complex GN
Glomerular immune deposits. The renal artery perfusion of
con A antigen followed by rabbit anti-con A IgG resulted in the
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Fig. 1. Electron micrograph of a glomerular capillary loop 10 minutes
after perfusion with con A antigen and anti-con A antibody. The
endothelium is coated with a dark "fuzzy" material (arrows) that may
represent antigen-antibody complexes. Numerous platelets are present.
The epithelial foot processes are intact. (E, epithelial cell; P, platelet;
(7000x).
glomerular capillary wall localization by IF of con A (4+),
rabbit IgG (4+) and rat C3 (3 to 4+) that was noted in the initial
biopsy at 10 minutes and remained at this intensity for the
remainder of the 24-hour study period. At 24 hours glomeruli
also stained strongly (2+) for the membrane attack complex of
complement.
Fibrin deposition in capillary walls was not detected by IF
until four hours after induction of GN, and by 24 hours hyaline
thrombi with positive IF staining for fibrinogen were present in
over 50% of the capillary loops.
Electron microscopy confirmed the presence of an electron-
dense "fuzzy" material (presumed antigen-antibody deposits)
that coated the endothelium at 10 minutes (Fig. 1), but by one
hour could also be demonstrated in subendothelial areas as well
as along basement membrane at sites of endothelial cell denu-
dation. EM was not performed at four and 24 hours.
Glomerular localization of platelets. The formation of im-
mune complex deposits was associated with a marked influx of
platelets that was maximal at 10 minutes (Figs. 1, 2). A smaller,
second phase of platelet accumulation was evident four hours
following induction of GN. In contrast, rats perfused with PBS
alone had minimal platelet localization in glomeruli at all times
studied (Fig. 2, Table 2).
The platelets could easily be visualized by light microscopy at
10 minutes as discrete cellular elements (Fig. 3). By EM the
platelets filled capillary lumina, and displayed signs of activa-
Fig. 2. Quantitative estimates and kinetics of platelet accumulation in
immune complex nephritis. The number of platelets isolated per gb-
merulus in rats perfused with con A and anti-con A antibody (solid line)
or PBS alone (dashed line) is shown over time. Platelet localization in
con A immune complex nephritis was biphasic with a major peak at 10
minutes and a minor peak at four hours. Platelet accumulation did not
occur in PBS-perfused controls.
Table 2. Number of platelets/glomerulus in normal, complement
depleted and WBC depleted rats with immune complex GN and PBS
perfused controls at various times following renal artery perfusion
PBS
Time Control GN C depleted WBC depleted perfused
10 mina 5733 756 (4) 70 l9L (4) 4118 548 (4) 91 36b (4)
30 mm 3023 363 (2) ND ND ND
I hra 1888 297 (5) 133 27" (4) 2242 264 (4) 67 10b (4)
4 hra 2514 154 (4) 55 10b (4) 1065 l78C (4) 84 24b (4)
24 hra 485 120 (5) 183 9C (4) 212 70C (4) 46 5b (4)
Values shown are mean SE. Number of animals for each set of
values is given in parentheses.
a P < 0.001 comparing the different groups at a specific time following
induction of GN by ANOVAb P < 0.001, P < 0.05 compared to control GN at same time by
Bonferroni method.
ND; not done.
tion including the centralization of granules and formation of
filopodia (Fig. 1). Evidence for platelet activation was also
suggested by the presence of fibrinogen on infiltrating platelets
by IF. Actual adherence of platelets to endothelium or exposed
subendothelial structures, however, was not noted by EM until
one hour following disease induction (Fig. 4). At this time some
of the platelets were noted to have electron-dense material
within vacuoles as well (Fig. 4).
Glomerular localization of PMNs. Whereas the platelet max-
imal infiltration had occurred by 10 minutes, PMN accumula-
tion was slower and did not peak until one and four hours
following induction of GN (Fig. 5). At one hour glomeruli
averaged 24 PMNs per cross section (Fig. 6) and in some
individual glomeruli as many as 40 PMNs could be detected.
Co
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Table 3. Number of PMNs/glomerular cross sectio
complex
n in normal, complement depleted, WBC depleted, and platelet dep
UN at various times following induction of GN
leted rats with immune
Time Control GN
WBC
C depleted depleted PLT depleted
10 mm
30 mm
1 hra
4 hra
24 hra
0.8 0.2 (4)
9.5 0.1 (2)
24.3 3.8 (5)
22.6 3.1 (4)
4.8 0.5 (5)
0.9 0.2 (4) 0.3 0.1 (4)
ND ND
5.8 15b (4) 0.6 0.3" (4)
4•5 10b (4) 1.7 0.5' (4)
1.8 04b (5) 0.8 0.6" (4)
3.5 2.2 (4)
ND
23.8 3.6 (4)
23.2 1.2 (4)
6.8 0.8 (4)
Values shown are mean SE. Number of animals for each set of values is given in parentheses.
a P < 0.001 comparing different groups at same time by ANOVAb p < 0.005, compared to control GN at same time by Bonferroni method
ND; not done.
endothelium, however, was largely intact except for focal areas
of cell swelling or degeneration which, when present, were
often associated with an intraluminal PMN.
A dramatic reduction in the platelet infiltration in glomeruli
was noted at all times following induction of GN in comple-
ment-depleted rats as compared to normal rats with IC nephritis
(Table 2). Complement depletion was also associated with
much less PMN infiltration (Fig. 6) at all times studied (Table 3).
However, an average of 5.8 and 4.2 PMNs per glomerular cross
section were noted at one and four hours, respectively. At 24
hours glomeruli also had an increase in mononuclear cells.
However, unlike control animals with IC nephritis, there was
no deposition of fibrinogen by IF, nor hyaline thrombi by light
microscopy at 4 and 24 hours.
Effect of WBC-depletion on immune complex nephritis
Fig. 3. Light microscopy of a glomerulus from a rat 10 minutes after
perfusion with con A and anti-con A antibody. The glomerulus appears
structurally normal, but numerous platelets are visible within capillary
lumina (PAS stain, 560 x).
EM pet-formed at one hour documented that the PMNs were
activated with filopodia, endocytic vacuoles, and occasional
phagocytosis of electron-dense material representing immune
complex aggregates or cellular debris (Fig. 4). Endothelial cell
injury, which was not prominent at 10 minutes, could now be
demonstrated and both PMNs and platelets were often adherent
to deposits or injured endothelium. Despite the inflammatory
infiltrates, the epithelial cell foot processes were largely intact
and only focal areas of effacement were noted. By 24 hours the
PMN infiltrate had largely subsided.
Effect of complement depletion on immune complex nephritis
Complement depletion was accomplished using CVF in 19
rats prior to induction of IC nephritis. Immunofluorescence at
all times studied documented equivalent amounts of con A
antigen (4+) and rabbit IgG (4+) as compared to control rats
with IC GN. However, unlike control rats, CVF treated rats
had negative glomerular staining for C3 and C5b-9 at all times,
except at four hours where trace C3 deposition was present in
three of four rats. EM localized the presumed IC deposits as
"fuzzy" densities coating the endothelium at 10 minutes. The
Severe leukocyte depletion (mean WBC count 80/mm3) was
accomplished in 16 rats with a combination of irradiation and
anti-PMN serum prior to induction of IC nephritis. Immune
complex nephritis in WBC-depleted rats was associated with
strong staining by IF for con A antigen (4+), rabbit IgG (4+)
and rat C3 (3 to 4+) in the capillary walls and was indistinguish-
able from normal rats with IC nephritis. The appearance of
C5b-9 in a granular pattern in the capillary walls was noted at
one and four hours and was of moderate intensity (2 to 3+) at 24
hours.
Leukocyte depletion did not affect the initial platelet accu-
mulation at 10 minutes and one hour (Table 2). Platelet accu-
mulation, however, was diminished at 4 and 24 hours in
WBC-depleted rats when compared to normal rats with IC
nephritis (P < 0.05), but this may have been accounted for by a
reduction in circulating platelet counts in WBC-depleted ani-
mals at these time points. When factored by circulating platelet
counts, the fraction of platelets localized in glomeruli in WBC-
depleted rats was the same as controls at 10 minutes and four
hours and higher at one and 24 hours.
By light microscopy the absence of inflammatory cell infil-
trates was apparent (Fig. 6). PMNs were only rarely identified
(Table 3). EM performed at one hour demonstrated moderate
endothelial cell injury with focal sloughing of cellular elements
into the capillary lumina and was often associated with accu-
mulations of platelets. Fibrinogen staining involved less than
10% of capillary loops at 24 hours, and corresponding light
microscopy likewise demonstrated only rare intracapillary
thrombi.
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Fig. 4. Electron micrograph of a glomerular
capillary loop one hour after perfusion with
con A and anti-con A antibody. Deposits are
visible on endothelium and in the
subendothelial space. A neutrophil is
observed engulfing electron-dense material
representing either immune complex
aggregates or cellular debris (arrow).
Activated platelets with similar electron-dense
material within vacuoles (arrow) are noted.
The endothelium is swollen and partially
denuded. The epithelial foot processes remain
relatively preserved. (C, capillary lumen; E,
epithelial cell; N, neutrophil; P, platelet)
(11,000x).
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Fig. 5. Kinetics of neutrophil localization in immune complex nephri-
tis. The number of neutrophils per glomerular cross section following
renal artery perfusion with con A and anti-con A antibody is shown
over time. Accumulation is maximal at 60 minutes and 4 hours.
Effects of platelet depletion on WBC localization in
IC nephritis
Severe thrombocytopenia (mean pit Ct <10,000/mm3) was
induced in 12 rats prior to induction of GN. Platelet-depleted
rats had comparable degrees of con A antigen (4±), rabbit IgG
(4+) and rat C3 (3+) in their glomet-uli by IF as compared to
normal rats with IC nephritis at all times. Staining for C5b-9 (1
to 2+) became most evident in rats studied 24 hours after
disease induction.
Table 4. 24-hr Urinary protein excretion in control, complement
depleted, WBC depleted and platelet depleted rats with immune
complex ON
Protein excretion
Groupa mg/24 hr N
Control GN 54 7
C depleted 26 44
WBC depleted 8 2b
PLT depleted 22 6C
PBS perfused 19 4b
6
7
4
4
4
Values shown are mean SE.
a P < 0.001 comparing groups by ANOVAbP < 0.001,
P < 0.005 compared to control GN by Bonferroni method
Platelet depletion did not alter PMN accumulation at any time
(Table 3, P = NS). Neutrophil infiltration was prominent (Fig.
6) and by EM PMNs exhibited signs of activation with intra-
cytoplasmic vacuoles and filopodia formation. The endothe-
hum, which was coated with the electron-dense "fuzzy" mate-
rial, was focally swollen and detached, and subendothelial
deposits could be demonstrated in many of the capillary loops.
Platelets remained conspicuously absent. By 24 hours, fibrin-
ogen staining was present in --25% of capillary loops, and was
associated with the presence of hyaline thrombi, but appeared
substantially less than in control rats with IC nephritis.
Effect of PMN, platelet or C depletion on protein excretion
The effect of WBC, platelet, and complement depletion on
the initial 24-hour protein excretion in the model of immune
complex nephritis is shown in Table 4. Protein excretion in rats
with IC nephritis averaged 59 7 mg/24 hr and was significantly
reduced in rats that were complement, WBC, or platelet de-
pleted.
10' 60' 4hr
tt;X
—
—"F
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Fig. 6. Lightmicroscopy 1 hour following perfusion of con A antigen and anti-con A antibody in normal (A), complement depleted (B), leukocyte
depleted (C) and plotelet depleted (D) rats. Prominent neutrophils are present within glomeruli in normal and platelet-depleted rats. Platelets are
visible within glomeruli in normal and WBC-depleted rats (arrows). Complement depleted glomeruli have occasional neutrophils, but otherwise
appear normal. (PAS stain 560x).
Discussion
We have studied a model of immune complex nephritis in the
rat characterized by primarily subendothelial immune deposits,
complement activation and PMN and platelet infiltration. This
model bears a striking immunohistologic similarity to several
types of human GN, such as type I membranoproliferative GN
and diffuse lupus nephritis, and studies of its mediation may be
relevant to these disorders. Our studies have previously dem-
onstrated that the proteinuria in this model is dependent on
PMNs [24] and platelets [16], and in this current report we have
provided evidence for the requirement of complement as well.
In the current study we have examined the kinetics of platelet
and PMN accumulation in glomeruli in the first 24 hours
following induction of GN. Platelet localization was quantitated
using '11lndium labeled platelets. Studies by others have dem-
onstrated that 'In-labeled platelets remain functional when
studied both in vitro and in vivo [27, 35, 36]. The injection of
"11n-labelled platelets with a nonspecific blood marker, 125J
IgG allowed us to determine the degree of platelet accumulation
in glomeruli above that which would be expected from blood
contamination alone. It is recognized, however, that we may
have underestimated the actual number of platelets localizing in
the glomeruli, as platelets that were not directly adherent could
have been lost during the glomerular isolation procedure.
Nevertheless, this method provided very reproducible mea-
surements for glomerular platelet accumulation, and had advan-
tages over the methods that have assessed glomerular platelet
localization indirectly by measuring the uptake of 51Cr-labeled
platelets by the renal cortex [37, 38].
Using this quantitative technique to measure glomerular
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platelet infiltration combined with serial light and EM, we were
able to demonstrate a marked platelet influx into glonieruli that
was maximal 10 minutes following glomerular immune complex
formation and complement activation. A marked platelet influx
has also been noted histologically by Fries, Mendrick and
Rennke in a similar subendothelial IC model utilizing con A
conjugated to ferritin followed by anti-ferritin antibody [39].
PMN infiltration occurred after the initial platelet influx, was
maximal at one and four hours, and was not dependent on it
since a similar PMN infiltration was noted in platelet-depleted
animals. Finally, both the platelet and PMN accumulation were
dependent on an intact complement system. Thus the mecha-
nism of the platelet enhancement of PMN-mediated injury
apparently occurs not by facilitating PMN localization but
rather may involve functional interactions between these cells
which occur after they have localized in glomeruli.
To examine the mechanisms responsible for platelet accumu-
lation in IC GN, we studied the effect of complement depletion
with cobra venom factor in rats prior to the induction of GN.
Although it is possible that cobra venom factor could adversely
affect platelet function independently of its ability to deplete
complement, in our study CVF did not depress circulating
platelet counts or impair 'In-platelet survival, and this is in
agreement with observations noted by others previously [40].
These studies are the first to demonstrate that localization of
platelets in glomeruli in immune complex GN is dependent on
complement activation. A potential mechanism could be via
interaction of platelet receptors with complement components.
Rat platelets contain C3b receptors [41] which could mediate
immune adherence to immune complex deposits. Guinea pig
platelets have receptors for C3a and C5a [42], but these
receptors have yet to be demonstrated on the rat platelet.
Another possibility is that complement activation might result
in platelet localization independent of specific complement
receptors in platelets, via direct injury to the endothelial cell
(perhaps via the membrane attack complex). Injury to the
endothelium could theoretically result in the release of inflam-
matory substances (such as platelet activating factor (PAF))
that could attract platelets to the site. Endothelial cell swelling
or denudation secondary to complement action might also
expose subendothelial matrix and basement membrane to
which platelets could bind avidly.
To further study the mechanisms responsible for platelet
localization in GN, we studied the effect of leukocyte depletion.
PMN depletion did not alter the initial platelet infiltration in our
model, nor does PMN depletion affect the initial platelet accu-
mulation in the reversed passive Arthus reaction [43]. A de-
crease in platelet infiltration was noted in WBC depleted rats at
4 and 24 hours, but this could be potentially explained by a
relative decrease in circulating platelet counts in these animals
at these times.
The kinetics for PMN localization in IC GN was also studied
serially by light microscopy. PMN infiltration in glomeruli
occurred after the early platelet influx. This is in contradistinc-
tion to cutaneous inflammation where platelet and PMN accu-
mulation are more temporally associated [271. The peak accu-
mulation of PMNs in our model occurred between one and four
hours, and is similar to that reported in nephrotoxic nephritis
[44]. By 24 hours the PMN and platelet infiltration had largely
subsided, and an increase in mononuclear cells was now
evident.
To study the mechanisms for PMN localization to glomeruli
in IC GN, a group of rats were complement depleted prior to
induction of GN. PMN accumulation in glomeruli was also
markedly attenuated in the absence of complement activation.
Prior studies have demonstrated the importance of complement
in PMN localization in the heterologous phase of nephrotoxic
nephntis [44]. Other PMN-mediated models such as the autol-
ogous phase of nephrotoxic nephntis in rabbits [45] and a
cationized IgG and anti-IgG model in rats [46] do not require
complement for PMN accumulation. The fact that some PMNs
were present in the glomeruli of our model despite treatment
with cobra venom factor suggests that either complement
depletion was not complete or that PMN localization may have
occurred due to other chemotactic factors, perhaps involving
immune adherence Fc receptors, as has been reported in the
autologous phase of nephrotoxic nephntis [47], or by direct
binding to endothelium via the recently described endothelial-
leukocyte adhesion molecules [48].
We also examined the possibility that platelets could influ-
ence the localization of PMNs in IC GN. Despite the fact that
platelets can produce chemotactic factors [49, 50], platelet-
depletion did not affect the glomerular localization of PMNs.
This differs from a study by Sindrey, Marshall and Naish in
which platelet depletion in the "passive" model of autologous
nephrotoxic nephritis was associated with a decrease in PMN
infiltration [51].
This study confirmed our previous studies that demonstrated
that both PMNs [25] and platelets [16] mediate proteinuna in
this disease model. Although a theoretical concern may be that
the minor depression in C3 noted in the platelet depleted rats
could have contributed to the decrease in proteinuria observed,
our prior study demonstrated that this degree of complement
depression does not influence the proteinuria [16].
The mechanism(s) by which the PMN and platelets interact to
induce injury was not addressed in this study. It is possible that
the effect is additive and that both platelets and PMNs damage
the glomerular capillary wall independent of each other. An-
other possibility is that platelets may augment PMN-mediated
injury. PMNs appear to mediate GN by releasing both reactive
oxygen species and proteases [reviewed in 52]. Recently, we
have provided evidence that both the myeloperoxidase-hy-
drogen peroxide-halide system [53] and the PMN neutral serine
proteases [54] can cause proteinuna and glomerular injury in
vivo. Thus it is of interest that platelets, perhaps via the release
of adenine nucleotides, can stimulate PMNs to release my-
eloperoxidase and superoxide anion [23]. Platelet factor 4 can
also potentiate elastase activity [55]. Other platelet products
such as PAF [56] and thromboxane [57] may also augment PMN
function. Further studies are necessary to determine if any of
these potential mechanisms is operative in vivo in this disease
model.
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